These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 652803)

  • 1. Live respiratory syncytial virus vaccine administered parenterally.
    Buynak EB; Weibel RE; McLean AA; Hilleman MR
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):636-42. PubMed ID: 652803
    [No Abstract]   [Full Text] [Related]  

  • 2. Further investigations of live respiratory syncytial virus vaccine administered parenterally.
    Buynak EB; Weibel RE; Carlson AJ; McLean AA; Hilleman MR
    Proc Soc Exp Biol Med; 1979 Feb; 160(2):272-7. PubMed ID: 419156
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
    Wright PF; Shinozaki T; Fleet W; Sell SH; Thompson J; Karzon DT
    J Pediatr; 1976 Jun; 88(6):931-6. PubMed ID: 178852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.
    Belshe RB; Van Voris LP; Mufson MA
    J Infect Dis; 1982 Mar; 145(3):311-9. PubMed ID: 7037983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.
    Chin J; Magoffin RL; Shearer LA; Schieble JH; Lennette EH
    Am J Epidemiol; 1969 Apr; 89(4):449-63. PubMed ID: 4305200
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory syncytial virus: virology, diagnosis, and vaccination.
    Toms GL
    Lung; 1990; 168 Suppl():388-95. PubMed ID: 1696677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus vaccine development.
    Kahn JS
    Curr Opin Pediatr; 2000 Jun; 12(3):257-62. PubMed ID: 10836163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
    Kim HW; Canchola JG; Brandt CD; Pyles G; Chanock RM; Jensen K; Parrott RH
    Am J Epidemiol; 1969 Apr; 89(4):422-34. PubMed ID: 4305198
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines.
    Watt PJ; Robinson BS; Pringle CR; Tyrrell DA
    Vaccine; 1990 Jun; 8(3):231-6. PubMed ID: 2363300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.
    Fulginiti VA; Eller JJ; Sieber OF; Joyner JW; Minamitani M; Meiklejohn G
    Am J Epidemiol; 1969 Apr; 89(4):435-48. PubMed ID: 4305199
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers.
    McKay E; Higgins P; Tyrrell D; Pringle C
    J Med Virol; 1988 Aug; 25(4):411-21. PubMed ID: 3171557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects of respiratory syncytial virus vaccines].
    Tarro G
    Ann Sclavo; 1980; 22(1):40-1. PubMed ID: 7247482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
    Kim HW; Arrobio JO; Brandt CD; Wright P; Hodes D; Chanock RM; Parrott RH
    Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of a workshop on respiratory syncytial virus and parainfluenza viruses.
    Tyeryar FJ
    J Infect Dis; 1983 Sep; 148(3):588-98. PubMed ID: 6194232
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccination against respiratory syncytial infection].
    Leshchinskaia NP
    Vopr Virusol; 1986; 31(5):517-27. PubMed ID: 3541385
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.
    McIntosh K; Fishaut JM
    Prog Med Virol; 1980; 26():94-118. PubMed ID: 6999535
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuated respiratory syncytial virus vaccines in asthmatic children.
    McIntosh K; Arbeter AM; Stahl MK; Orr IA; Hodes DS; Ellis EF
    Pediatr Res; 1974 Jul; 8(7):689-96. PubMed ID: 4601222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle vaccines against respiratory viruses.
    Adair BM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):405-14. PubMed ID: 20049806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.
    Kapikian AZ; Mitchell RH; Chanock RM; Shvedoff RA; Stewart CE
    Am J Epidemiol; 1969 Apr; 89(4):405-21. PubMed ID: 4305197
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine.
    Sweet BH; Tytell AA; Potash L; Weibel RE; Stokes J; Drake ME; Woodhour AF; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):340-9. PubMed ID: 4288342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.